Symbol="ALLR"
AssetType="Common Stock"
Name="Allarity Therapeutics Inc"
Description="Allarity Therapeutics A / S develops various therapeutic candidates for the treatment of cancer using complementary drug-specific diagnostics (cDx) generated by its drug response prediction technology. The company is headquartered in Horsholm, Denmark."
CIK="1860657"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="210 BROADWAY, SUITE 201, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="177036000"
EBITDA="-16202000"
PERatio="0.019"
PEGRatio="None"
BookValue="-2.61"
DividendPerShare="0"
DividendYield="0"
EPS="436.03"
RevenuePerShareTTM="-0.018"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.462"
ReturnOnEquityTTM="-1.975"
RevenueTTM="-7127000"
GrossProfitTTM="-36348000"
DilutedEPSTTM="436.03"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="5"
TrailingPE="0.019"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="2.659"
EVToRevenue="-"
EVToEBITDA="-0.0989"
Beta="-0.0032"
num_52WeekHigh="2435.86"
num_52WeekLow="5.64"
num_50DayMovingAverage="11.69"
num_200DayMovingAverage="420.87"
SharesOutstanding="503560"
DividendDate="None"
ExDividendDate="None"
symbol="ALLR"
open="6.20"
high="13.49"
low="5.64"
price="8.28"
volume="11352887.00"
latest_trading_day="2023-07-05"
previous_close="6.30"
change="1.98"
change_percent="31.4286%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="4139040"
Change_recent_avg="-0.01"
Delta_recent_avg="0.25"
Variance_recent_avg="0.13"
Change_ratio_recent_avg="-3.18"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="515"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0090.jpeg"
image_negative_thumbnail_id_2="136"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0040.jpeg"
image_neutral_thumbnail_id_1="578"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0021.jpeg"
image_neutral_thumbnail_id_2="533"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0066.jpeg"
image_positive_thumbnail_id_1="973"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0135.jpeg"
image_positive_thumbnail_id_2="959"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0121.jpeg"
image_professor_thumbnail_id_1="1178"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0012.jpeg"
image_professor_thumbnail_id_2="1185"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0019.jpeg"
